About
About SSY Group Limited
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; research, development of biotechnology and related roducts; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. SSY Group Limited was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
Visit company website
5 years, 5 months ago
SSY Group Limited is currently in a long term uptrend where the price is trading 65.0% above its 200 day moving average.
From a valuation standpoint, the stock is 97.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.
SSY Group Limited's total revenue rose by 7.3% to $2B since the same quarter in the previous year.
Its net income has dropped by 37.9% to $365M since the same quarter in the previous year.
Finally, its free cash flow grew by 109.4% to $55M since the same quarter in the previous year.
Based on the above factors, SSY Group Limited gets an overall score of 4/5.